CORT(Corcept Therapeutics Incorporated) · 财务报表

CORT(Corcept Therapeutics Incorporated) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$365.98M$401.86M$482.38M$675.04M$761.41M
毛利润$360.70M$396.47M$475.89M$664.16M$748.43M
营业利润$124.48M$112.63M$107.28M$136.95M$44.80M
净利润$112.51M$101.42M$106.14M$141.21M$99.65M
经营现金流$167.89M$120.32M$126.68M$198.29M$142.00M
自由现金流$167.42M$119.91M$126.54M$196.12M$141.78M
摊薄每股收益$0.89$0.87$0.94$1.23$0.82

Corcept Therapeutics Incorporated CORT